RecruitingNCT06040827

A Multicenter, Postmarket Surveillance Study of Subjects With the Canary canturioTM te Tibial Extension


Sponsor

Canary Medical

Enrollment

626 participants

Start Date

Sep 12, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The objectives of this prospective observational cohort study are to evaluate the safety, reliability, reproducibility, and accuracy of the Canary canturioTM te post-TKA.


Eligibility

Min Age: 18 Years

Inclusion Criteria9

  • Patient must be 18 years of age or older
  • Patient qualifies for primary total knee arthroplasty based on physical exam and medical history, including diagnosis of severe knee pain and disability due to osteoarthritis, limited to:
  • Mild or Moderate valgus, varus, or flexion deformities
  • Patient must be willing and able to complete the protocol required follow-up
  • Patient is indicated for a 58mm or 30mm tibial stem extension
  • Patient has participated in the study-related informed consent process
  • Patient is willing and able to provide written Informed Consent by signing and dating the IRB approved informed consent
  • Patient has a platform-compatible personal computer located in their dwelling with appropriate wireless internet access and a USB port
  • Independent of study participation, patient is a candidate for commercially available Persona Personalized Knee System implanted in accordance with product labeling

Exclusion Criteria17

  • Simultaneous bilateral TKA
  • Staged bilateral TKA less than 6 months from indexed procedure
  • Patient is a current alcohol or drug abuser
  • Patient is known to be pregnant, breastfeeding, or considered a member of a protected class (e.g., prisoner, mentally incompetent, etc.)
  • Patient has a psychiatric illness or cognitive deficit that will not allow proper informed consent and participation in follow-up program
  • Patient has previous history of infection in the affected joint and/or a local or systemic infection that may affect the prosthetic joint
  • Patient with mental or neurologic conditions who are unwilling or incapable of following postoperative care instructions
  • Patient with skeletal immaturity
  • Patient has insufficient bone stock on femoral or tibial surfaces
  • Patient with Neuropathic Arthropathy
  • Patient has osteoporosis, or any loss of musculature or neuromuscular disease that compromises the affected limb
  • Patient has severe instability secondary to the absence of collateral ligament integrity.
  • Patient has a stable, painless arthrodesis in a satisfactory functional position
  • Patient has rheumatoid arthritis accompanied by an ulcer of the skin or a history of recurrent breakdown of the skin
  • Patient has a known or suspected sensitivity to one or more of the implant materials
  • Patient is undergoing procedures or treatments using ionizing radiation
  • Patients with known symptomatic foot, hip, or spinal injuries and/or conditions that could affect gait

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETotal Knee Arthroplasty

The nature, severity, and frequency of safety risks (Adverse Events) in subjects with the Canary canturioTM te will be compared to those subjects with the legally marketed Zimmer Persona® Personalized Knee System with 14 mm x +30 mm stem extension within 5 years post-TKA.


Locations(7)

Ozark Orthopaedics

Fayetteville, Arkansas, United States

Foundation For Orthopaedic Research and Education

Tampa, Florida, United States

Northside Hospital

Atlanta, Georgia, United States

South Bend Orthopaedics

South Bend, Indiana, United States

Cleveland Clinic

Cleveland, Ohio, United States

JIS Research Institute

New Albany, Ohio, United States

Carolina Orthopaedic & Neurosurgical Associates

Spartanburg, South Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06040827


Related Trials